X4 Pharmaceuticals Inc. (XFOR): שווי כולל של נכסי החברה
X4 Pharmaceuticals (XFOR) specializes in the therapy of rare immune pathologies, mitigating the risks of a narrow portfolio by launching a key oral agent into the US market. Financial flow stability is strengthening as the approved drug undergoes commercialization. Total assets amount to 179.13, while the daily price action reflects the use of external CDMO facilities for production, which eliminates capacity downtime at the Massachusetts centers.
פילוחי מדדים מקיפים ואנליטיקה עבור X4 Pharma (XFOR)
Total assets, reverse-calculated via return on assets (ROA), determine the aggregate value of resources and liabilities, allowing for an assessment of the actual scale of the business regardless of market volatility. By analyzing the assets of X4 Pharmaceuticals (XFOR) through ROA, an investor separates operational resilience from random spikes, which is critically important for X4 Pharmaceuticals (XFOR) in ensuring the complex logistics of drugs for the treatment of rare immune disorders.